Healios K.K. logo

Healios K.K.

TSE:4593.T

Overview | Financials
Company Name Healios K.K.
Symbol 4593.T
Currency JPY
Price 224
Market Cap 20,189,120,448
Dividend Yield 0%
52-week-range 114 - 255
Industry Biotechnology
Sector Healthcare
CEO Dr. Tadahisa S. Kagimoto M.D.
Website https://www.healios.co.jp

An error occurred while fetching data.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration;

Related Stocks

MTI Ltd. logo

MTI Ltd.

9438.T

1,141 JPY

FALCO HOLDINGS Co., Ltd. logo

FALCO HOLDINGS Co., Ltd.

4671.T

2,330 JPY

Medius Holdings Co., Ltd. logo

Medius Holdings Co., Ltd.

3154.T

815 JPY

Kanamic Network Co.,LTD logo

Kanamic Network Co.,LTD

3939.T

546 JPY

I'rom Group Co., Ltd. logo

I'rom Group Co., Ltd.

2372.T

2,784 JPY

Fuji Pharma Co., Ltd. logo

Fuji Pharma Co., Ltd.

4554.T

1,232 JPY

Mizuho Medy Co.,Ltd. logo

Mizuho Medy Co.,Ltd.

4595.T

1,557 JPY

Data Horizon Corporation logo

Data Horizon Corporation

3628.T

490 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD